0001225208-17-003413.txt : 20170215 0001225208-17-003413.hdr.sgml : 20170215 20170215165846 ACCESSION NUMBER: 0001225208-17-003413 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170213 FILED AS OF DATE: 20170215 DATE AS OF CHANGE: 20170215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beasley Jim C CENTRAL INDEX KEY: 0001463423 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 17615367 MAIL ADDRESS: STREET 1: C/O C. R. BARD, INC. STREET 2: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 doc4.xml X0306 4 2017-02-13 0000009892 BARD C R INC /NJ/ BCR 0001463423 Beasley Jim C C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 Group President Common Stock 2017-02-13 4 F 0 511.0000 240.4700 D 27875.0000 D Common Stock 2017-02-13 4 F 0 1693.0000 240.4700 D 25448.0000 D Common Stock 2017-02-14 4 S 0 3213.0000 240.5215 D 22235.0000 D Common Stock 3116.7360 I 401(k) Plan Shares withheld to pay taxes upon vesting of restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Shares withheld to pay taxes upon vesting of restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program. Sales are pursuant to a previously disclosed 10b5-1 plan. Represents the weighted average sales price for price increments ranging from $240.31 to $240.88. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. The amounts in Column 5 (Amount of Securities Beneficially Owned Following Reported Transactions) includes a transaction reported on the Form 4 filed on February 14, 2017. The ending balance reflects the current amount of securities beneficially owned. Myra McGinley, Attorney-in-Fact 2017-02-15